Cited by 230Genomic variations and chromosomal abnormalitiesCancer Genomics and DiagnosticsChromatin Remodeling and Cancer

The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.

Chromosomal Abnormalities in Cancer

Fröhling, Stefan, Döhner, Hartmut·2008·New England Journal of Medicine

DOI 10.1056/nejmra0803109

Open this paper in CoChat — free account

Abstract

This review gives an account of chromosomal aberrations in cancer cells. Such abnormalities have typically been associated with hematologic cancers, but recent work has shown a variety of chromosomal changes in solid tumors, including prostate cancer and non–small-cell lung cancer. The authors point out that some of the chromosomal abnormalities have revealed targets for cancer treatment, and others have clinical application in the diagnosis of certain types of neoplasms and in the formulation of a prognosis.

Integrity signals

Registry

Crossref · 10.1056/nejmra0803109

Cites

94 of 94 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W. J., Jones, L. A., Holt, J. A., Wong, S., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J. A., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,817
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
Soda, M., Choi, Y. L., Enomoto, M., Takada, S., Yamashita, Y., Ishikawa, S., Fujiwara, S.-I., Watanabe, H., Kurashina, K., Hatanaka, H., et al. (2007) · Nature · doi:10.1038/nature05945 · Cited by 5,439
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
Engelman, J. A., Zejnullahu, K., Mitsudomi, T., Song, Y., Hyland, C., Park, J. O., Lindeman, N., Gale, C.-M., Zhao, X., Christensen, J., et al. (2007) · Science · doi:10.1126/science.1141478 · Cited by 4,496
A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining
ROWLEY, J. D. (1973) · Nature · doi:10.1038/243290a0 · Cited by 4,291
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,096
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
miR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,579
Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
Druker, B. J., Guilhot, F., O’Brien, S. G., Gathmann, I., Kantarjian, H. M., Gattermann, N., Deininger, M. W., Silver, R. T., Goldman, J. M., Stone, R. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062867 · Cited by 3,516
Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia
Döhner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Kröber, A., Bullinger, L., Döhner, K., Bentz, M., & Lichter, P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432602 · Cited by 3,316
Self-citation

Flagged first, then by citations

Show all 94 references

Research works printed but not linked: 1

Nowell PC, 1960, J Natl Cancer Inst, 25, 85

Sorted by citations

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Döhner, H., Estey, E. H., Amadori, S., Appelbaum, F. R., Büchner, T., Burnett, A. K., Dombret, H., Fenaux, P., Grimwade, D. J., Larson, R. A., et al. (2009) · Blood · doi:10.1182/blood-2009-07-235358 · Cited by 3,438
Self-citation
Eph receptors and ephrins in cancer: bidirectional signalling and beyond
Pasquale, E. B. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2806 · Cited by 1,246
A Single Oncogenic Enhancer Rearrangement Causes Concomitant EVI1 and GATA2 Deregulation in Leukemia
Gröschel, S., Sanders, M. A., Hoogenboezem, R., de Wit, E., Bouwman, B. A. M., Erpelinck, C., van der Velden, V. H. J., Havermans, M., Avellino, R., van Lom, K., et al. (2014) · Cell · doi:10.1016/j.cell.2014.02.019 · Cited by 687
Self-citation
Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies
Smallridge, R. C., Marlow, L. A., & Copland, J. A. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0154 · Cited by 396
The role of enhancers in cancer
Sur, I., & Taipale, J. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.62 · Cited by 393
The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis
Pettersson, A., Graff, R. E., Bauer, S. R., Pitt, M. J., Lis, R. T., Stack, E. C., Martin, N. E., Kunz, L. M., Penney, K. L., Ligon, A. H., et al. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0042 · Cited by 318
SOAPfuse: an algorithm for identifying fusion transcripts from paired-end RNA-Seq data
Jia, W., Qiu, K., He, M., Song, P., Zhou, Q., Zhou, F., Yu, Y., Zhu, D., Nickerson, M. L., Wan, S., et al. (2013) · Genome biology · doi:10.1186/gb-2013-14-2-r12 · Cited by 206
SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer
Wilbertz, T., Wagner, P. L., Petersen, K., Stiedl, A., Scheble, V. J., Maier, S. H., Reischl, M., Mikut, R., Altorki, N. K., Moch, H., et al. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.49 · Cited by 198
Primary Malignant Tumors of the Spine
Sundaresan, N., Rosen, G., & Boriani, S. (2008) · Orthopedic Clinics of North America · doi:10.1016/j.ocl.2008.10.004 · Cited by 174
The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma
Pechloff, K., Holch, J. W., Ferch, U., Schweneker, M., Brunner, K., Kremer, M., Sparwasser, T. D., Quintanilla‐Martínez, L., Zimber‐Strobl, U., Streubel, B., et al. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20092042 · Cited by 164
BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate Cancer
Li, X., Baek, G., Ramanand, S. G., Sharp, A., Gao, Y., Yuan, W., Welti, J., Rodrigues, D. N., Dolling, D., Figueiredo, I., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.078 · Cited by 148
Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis
Bullinger, L., Krönke, J., Schön, C., Radtke, I., Urlbauer, K., Botzenhardt, U., Gaidzik, V., Carió, A., Senger, C., Schlenk, R. F., et al. (2009) · Leukemia · doi:10.1038/leu.2009.263 · Cited by 141
Self-citation
Collateral lethality: a new therapeutic strategy in oncology
Muller, F. L., Aquilanti, E. A., & DePinho, R. A. (2015) · Trends in Cancer · doi:10.1016/j.trecan.2015.10.002 · Cited by 132
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y., Khan, S., Huo, Z., Lv, D., Zhang, X., Liu, X., Yuan, Y., Hromas, R., Xu, M., Zheng, G., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00924-z · Cited by 126
The Role of Mechanistic Factors in Promoting Chromosomal Translocations Found in Lymphoid and Other Cancers
Zhang, Y., Gostissa, M., Hildebrand, D. G., Becker, M. S., Boboilă, C., Chiarle, R., Lewis, S. M., & Alt, F. W. (2010) · Advances in immunology · doi:10.1016/s0065-2776(10)06004-9 · Cited by 135
NCLscan: accurate identification of non-co-linear transcripts (fusion,trans-splicing and circular RNA) with a good balance between sensitivity and precision
Chuang, T., Wu, C.-S., Chen, C.-Y., Hung, L.-Y., Chiang, T.-W., & Yang, M.-Y. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1013 · Cited by 124
Health Changes in Fishermen 2 Years After Clean-up of the Prestige Oil Spill
Rodríguez-Trigo, G., Zock, J.-P., Pozo-Rodríguez, F., Gómez, F. P., Monyarch, G., Bouso, L., Coll, M. D., Verea, H., Antó, J. M., Fuster, C., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-8-201010190-00279 · Cited by 94
Immunomodulatory effect of mushrooms and their bioactive compounds in cancer: A comprehensive review
Pathak, M. P., Pathak, K., Saikia, R., Gogoi, U., Ahmad, M. Z., Patowary, P., & Das, A. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112901 · Cited by 91
Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia
Ottema, S., Mulet‐Lazaro, R., Beverloo, H. B., Erpelinck-Verschueren, C. A. J., van Herk, S., van der Helm, R. M., Havermans, M., Grob, T., Valk, P. J. M., Bindels, E. M., et al. (2020) · Blood · doi:10.1182/blood.2019003701 · Cited by 81
Transcriptional control by enhancers and enhancer RNAs
Lewis, M. W., Shen, L., & Franco, H. L. (2019) · Transcription · doi:10.1080/21541264.2019.1695492 · Cited by 84
Gene Copy-Number Variation in Haploid and Diploid Strains of the Yeast Saccharomyces cerevisiae
Zhang, H., Zeidler, A. F., Song, W., Puccia, C. M., Malc, E. P., Greenwell, P. W., Mieczkowski, P. A., Petes, T. D., & Argueso, J. L. (2013) · Genetics · doi:10.1534/genetics.112.146522 · Cited by 83
Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 1: Human papillomavirus-mediated carcinogenesis
Feller, L., Wood, N. H., Khammissa, R. A. G., & Lemmer, J. (2010) · Head & Face Medicine · doi:10.1186/1746-160x-6-14 · Cited by 71
A kernel-based integration of genome-wide data for clinical decision support
Daemen, A., Gevaert, O., Ojeda, F., Debucquoy, A., Suykens, J. A. K., Sempoux, C. L., Machiels, J., Haustermans, K. M., & Moor, B. D. (2009) · Genome Medicine · doi:10.1186/gm39 · Cited by 70
Cancer Somatic Mutations Disrupt Functions of the EphA3 Receptor Tyrosine Kinase through Multiple Mechanisms
Lisabeth, E. M., Fernandez, C., & Pasquale, E. B. (2012) · Biochemistry · doi:10.1021/bi2014079 · Cited by 67
Oncogenic chromosomal translocations and human cancer (Review)
Zheng, J. (2013) · Oncology Reports · doi:10.3892/or.2013.2677 · Cited by 70
Diagnostic Molecular Biomarkers for Malignant Pleural Effusions
Sriram, K. B., Relan, V., Clarke, B. E., Duhig, E., Yang, I. A., Bowman, R., Lee, G., & Fong, K. M. (2011) · Future Oncology · doi:10.2217/fon.11.45 · Cited by 62
Scrambling the genome in cancer: causes and consequences of complex chromosome rearrangements
Krupina, K., Goginashvili, A., & Cleveland, D. W. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-023-00663-0 · Cited by 63
Fibroblast growth factor receptor 1 amplification is a common event in squamous cell carcinoma of the head and neck
Göke, F., Bode, M., Franzen, A., Kirsten, R., Goltz, D., Göke, A., Sharma, R. K., Boehm, D., Vogel, W., Wagner, P. L., et al. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.58 · Cited by 58
High Mobility Group AT-Hook 2 (HMGA2) Oncogenicity in Mesenchymal and Epithelial Neoplasia
Unachukwu, U. J., Chada, K. K., & D'Armiento, J. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093151 · Cited by 58
Anti-apoptotic Protein BCL2 Down-regulates DNA End Joining in Cancer Cells
Tadi, S. K., Kari, V., Choudhary, B., Nambiar, M., Akila, T. S., & Raghavan, S. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.140350 · Cited by 57
rSW-seq: Algorithm for detection of copy number alterations in deep sequencing data
Kim, T., Luquette, L. J., Xi, R., & Park, P. J. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-432 · Cited by 57
The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment
Despierre, E., Lambrechts, D., Neven, P., Amant, F. C., Lambrechts, S., & Vergote, I. B. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.02.012 · Cited by 55
Biomolecular condensates: hubs of Hippo-YAP/TAZ signaling in cancer
Kiang, K. M. Y., Ahad, L., Zhong, X., & Lu, Q. R. (2024) · Trends in Cell Biology · doi:10.1016/j.tcb.2024.04.009 · Cited by 56
Genomic Profiling of Advanced-Stage Oral Cancers Reveals Chromosome 11q Alterations as Markers of Poor Clinical Outcome
Ambatipudi, S., Gerstung, M., Gowda, R., Pai, P., Borges, A. M., Schäffer, A. A., Beerenwinkel, N., & Mahimkar, M. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017250 · Cited by 56
The structural basis for cancer treatment decisions
Nussinov, R., Jang, H., & Tsai, C. (2014) · Oncotarget · doi:10.18632/oncotarget.2439 · Cited by 51
Acute Lymphoblastic Leukemia: Introduction
Pui, C. (2008) · Seminars in Hematology · doi:10.1053/j.seminhematol.2008.09.011 · Cited by 50
Rationale for Treatment of Metastatic Squamous Cell Carcinoma of the Lung Using Fibroblast Growth Factor Receptor Inhibitors
Göke, F., Franzen, A., Menon, R., Goltz, D., Kirsten, R., Boehm, D., Vogel, W., Göke, A., Scheble, V. J., Ellinger, J., et al. (2012) · CHEST Journal · doi:10.1378/chest.11-2943 · Cited by 48
Clinical Implications of TMPRSS2-ERG Gene Fusion Expression in Patients With Prostate Cancer Treated With Radical Prostatectomy
Rubio‐Briones, J., Fernández‐Serra, A., Calatrava, A. M., García‐Casado, Z., Rubio, L., Bonillo-García, M. Á., Iborra, I., Solsona, E., & López‐Guerrero, J. A. (2010) · The Journal of Urology · doi:10.1016/j.juro.2009.12.096 · Cited by 48
Nanotechnology of Tyrosine Kinase Inhibitors in Cancer Therapy: A Perspective
Russo, E., Spallarossa, A., Tasso, B., Villa, C., & Brullo, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126538 · Cited by 47
Lipid metabolism and its implications in tumor cell plasticity and drug resistance: what we learned thus far?
Vishwa, R., BharathwajChetty, B., Girisa, S., Aswani, B. S., Alqahtani, M. S., Abbas, M. A. E., Hegde, M., & Kunnumakkara, A. B. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10170-1 · Cited by 49
MicroRNA expression in acute myeloid leukemia
Marcucci, G., Radmacher, M. D., Mrózek, K., & Bloomfield, C. D. (2009) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-009-0012-7 · Cited by 46
Watching the grin fade: Tracing the effects of polyploidy on different evolutionary time scales
Mayfield‐Jones, D., Washburn, J. D., Arias, T., Edger, P. P., Pires, J. C., & Conant, G. C. (2013) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2013.02.002 · Cited by 46
Molecular signatures in acute myeloid leukemia
Mrózek, K., Radmacher, M. D., Bloomfield, C. D., & Marcucci, G. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283257b42 · Cited by 51
Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemia
Ernst, T., Score, J., Deininger, M. W., Hidalgo-Curtis, C., Lackie, P. M., Ershler, W. B., Goldman, J. M., Cross, N. C. P., & Grand, F. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08457.x · Cited by 45
Structural chromosomal aberrations as potential risk markers in incident cancer patients
Vodenková, S., Polívková, Z., Mušák, Ľ., Šmerhovský, Z., Zoubková, H., Sytarova, S., Kavcová, E., Halášová, E., Vodičková, Ľ., Jirásková, K., et al. (2015) · Mutagenesis · doi:10.1093/mutage/gev018 · Cited by 44
FuseFISH: Robust Detection of Transcribed Gene Fusions in Single Cells
Semrau, S., Crosetto, N., Bienko, M., Boni, M., BERNASCONI, P. P., Chiarle, R., & van Oudenaarden, A. (2014) · Cell Reports · doi:10.1016/j.celrep.2013.12.002 · Cited by 43
Convergent Evolution and the Origin of Complex Phenotypes in the Age of Systems Biology
Washburn, J. D., Bird, K. A., Conant, G. C., & Pires, J. C. (2016) · International Journal of Plant Sciences · doi:10.1086/686009 · Cited by 43
Zinc-chitosan nanoparticles induced apoptosis in human acute T-lymphocyte leukemia through activation of tumor necrosis factor receptor CD95 and apoptosis-related genes
Saravanakumar, K., Elango, J., Chelliah, R., Kathiresan, K., Wu, W., Oh, D., & Wang, M. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.08.017 · Cited by 42
HSP70 colocalizes with PLK1 at the centrosome and disturbs spindle dynamics in cells arrested in mitosis by arsenic trioxide
Chen, Y., Lai, K., Kuo, H., Chow, L., Yih, L., & Lee, T. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1222-x · Cited by 41
Amplification of the EGFR and CCND1 Are Coordinated and Play Important Roles in the Progression of Oral Squamous Cell Carcinomas
Chien, H., Cheng, S., Liao, C., Wang, H., & Huang, S. (2019) · Cancers · doi:10.3390/cancers11060760 · Cited by 41
Dominant-negative mechanism of leukemogenic PAX5 fusions
Kawamata, N., Pennella, M. A., Woo, J. L., Berk, A. J., & Koeffler, H. P. (2011) · Oncogene · doi:10.1038/onc.2011.291 · Cited by 42
Role of chromosomal aberrations in clonal diversity and progression of acute myeloid leukemia
Bochtler, T., Fröhling, S., & Krämer, A. (2015) · Leukemia · doi:10.1038/leu.2015.32 · Cited by 39
Self-citation
Pathology, genetics and cytogenetics of Wilms’ tumour
Zin, R. M., Murch, A. R., & CHARLES, A. K. (2011) · Pathology · doi:10.1097/pat.0b013e3283463575 · Cited by 39
State of the Art Management in Spine Oncology
Sundaresan, N., Boriani, S., & Okuno, S. H. (2009) · Spine · doi:10.1097/brs.0b013e3181bac476 · Cited by 39
PML-RARA can increase hematopoietic self-renewal without causing a myeloproliferative disease in mice
Welch, J. S., Yuan, W., & Ley, T. J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42953 · Cited by 38
Fibroblast growth factor receptor-1 as a potential therapeutic target in sinonasal cancer
Schröck, A., Göke, F., Wagner, P. L., Bode, M., Franzen, A., Huss, S., Agaimy, A., Ihrler, S., Kirsten, R., Kristiansen, G., et al. (2013) · Head & Neck · doi:10.1002/hed.23443 · Cited by 38
Malignant Transformation of a Dysembryoplastic Neuroepithelial Tumor (DNET) Characterized by Genome-Wide Methylation Analysis
Heiland, D. H., Staszewski, O., Hirsch, M., Masalha, W., Franco, P., Grauvogel, J., Capper, D., Schrimpf, D., Urbach, H., & Weyerbrock, A. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw007 · Cited by 38
Sex Determining Region Y-Box 2 (SOX2) Amplification Is an Independent Indicator of Disease Recurrence in Sinonasal Cancer
Schröck, A., Göke, F., Wagner, P. L., Bode, M., Franzen, A., Braun, M., Huss, S., Agaimy, A., Ihrler, S., Menon, R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059201 · Cited by 37
An epigenetic perspective on tumorigenesis: Loss of cell identity, enhancer switching, and NamiRNA network
Liang, Y. J., Xu, P., Zou, Q., Luo, H., & Yu, W. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.09.004 · Cited by 37
Comparative Oncogenomic Analysis of Copy Number Alterations in Human and Zebrafish Tumors Enables Cancer Driver Discovery
Zhang, G., Hoersch, S., Amsterdam, A., Whittaker, C. A., Beert, E., Catchen, J., Farrington, S. M., Postlethwait, J. H., Legius, E., Hopkins, N. H., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003734 · Cited by 35
In vivo modeling of metastatic human high-grade serous ovarian cancer in mice
Kim, O., Park, E. Y., Klinkebiel, D. L., Pack, S., Shin, Y.-H., Abdullaev, Z., Emerson, R. E., Coffey, D. M., Kwon, S. Y., Creighton, C. J., et al. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008808 · Cited by 34
Inhibition of G1 to S Phase Progression by a Novel Zinc Finger Protein P58TFL at P-bodies
Minagawa, K., Katayama, Y., Nishikawa, S., Yamamoto, K., Sada, A., Okamura, A., Shimoyama, M., & Matsui, T. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0511 · Cited by 33
The Ty1 transposition assay: a new short-term test for detection of carcinogens
Pesheva, M. G., Krastanova, O., Staleva, L., Dentcheva, V., Hadzhitodorov, M., & Venkov, P. (2004) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2004.10.001 · Cited by 33
Fluorescence in situ hybridization analysis with a tissue microarray: ‘FISH and chips’ analysis of pathology archives
Sugimura, H., Mori, H., Nagura, K., Kiyose, S., Hong, T., Isozaki, M., Igarashi, H., Shinmura, K., Hasegawa, A., Kitayama, Y., et al. (2010) · Pathology International · doi:10.1111/j.1440-1827.2010.02561.x · Cited by 32
Therapeutic potential of siRNA and DNAzymes in cancer
Karnati, H. K., Yalagala, R. S., Undi, R. B., Pasupuleti, S. R., & Gutti, R. K. (2014) · Tumor Biology · doi:10.1007/s13277-014-2477-9 · Cited by 32
Targeted therapy of chronic myeloid leukemia
Sullivan, C., Peng, C., Chen, Y., Li, D., & Li, S. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.05.001 · Cited by 32
An epigenetic perspective on tumorigenesis: Loss of cell identity, enhancer switching, and NamiRNA network
Liang, Y. J., Xu, P., Zou, Q., Luo, H., & Yu, W. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.09.001 · Cited by 32
Comparative analysis of algorithms for integration of copy number and expression data
Louhimo, R., Lepikhova, T., Monni, O., & Hautaniemi, S. (2012) · Nature Methods · doi:10.1038/nmeth.1893 · Cited by 30
Genomic instability and copy‐number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas
Bayani, J., Marrano, P. M., Graham, C., Zheng, Y., Li, L., Katsaros, D., Lassus, H. J., Bützow, R. C., Squire, J. A., & Diamandis, E. P. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.08.002 · Cited by 30
Advanced Cancer: Emergence of a New Survivor Population
Haylock, P. J. (2010) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2010.05.008 · Cited by 30
Viewing the Eph receptors with a focus on breast cancer heterogeneity
Nikas, I. P., Ryu, H. S., & Theocharis, S. E. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.07.030 · Cited by 30
Genomic profiling of canine mast cell tumors identifies DNA copy number aberrations associated with KIT mutations and high histological grade
Mochizuki, H., Thomas, R. J., Moroff, S. D., & Breen, M. (2017) · Chromosome Research · doi:10.1007/s10577-016-9543-7 · Cited by 33
Sex chromosome loss and the pseudoautosomal region genes in hematological malignancies
Weng, S., Stoner, S. A., & Zhang, D. (2016) · Oncotarget · doi:10.18632/oncotarget.12050 · Cited by 28
Genetic deletions in AML and MDS
Ebert, B. L. (2010) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2010.09.006 · Cited by 27
Lifetime Follow-up Care After Childhood Cancer
Haddy, R. I., & Haddy, T. B. (2010) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2010.05.100031 · Cited by 27
A time stamp comparative analysis of frequent chromosomal abnormalities in Romanian patients
Suciu, N., & Plăiaşu, V. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.794215 · Cited by 27
Cytogenomics of cancers: From chromosome to sequence
Bernheim, A. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.06.003 · Cited by 28
MicroRNA expression profiling in acute myeloid and chronic lymphocytic leukaemias
Marcucci, G., Mrózek, K., Radmacher, M. D., Bloomfield, C. D., & Croce, C. M. (2009) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2009.05.003 · Cited by 27
Ubc4 and Not4 Regulate Steady-State Levels of DNA Polymerase-α to Promote Efficient and Accurate DNA Replication
Haworth, J. C., Alver, R. C., Anderson, M. A., & Bielinsky, A. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-06-0452 · Cited by 26
Loss of 5q in myeloid malignancies – A gain in understanding of biological and clinical consequences
Venugopal, S., Mascarenhas, J. O., & Steensma, D. P. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100735 · Cited by 26
Development and Characterization of MYB-NFIB Fusion Expression in Adenoid Cystic Carcinoma
Humtsoe, J. O., Kim, H., Jones, L., Cevallos, J., Boileau, P., Kuo, F., Morris, L. G. T., & Ha, P. K. (2022) · Cancers · doi:10.3390/cancers14092263 · Cited by 25
RNA interference as an anticancer therapy: a patent perspective
Dykxhoorn, D. M. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770902838008 · Cited by 25
Detection of Copy Number Imbalance in Canine Urothelial Carcinoma With Droplet Digital Polymerase Chain Reaction
Mochizuki, H., Shapiro, S. G., & Breen, M. (2015) · Veterinary Pathology · doi:10.1177/0300985815614975 · Cited by 25
SN-38 Conjugated Gold Nanoparticles Activated by Ewing Sarcoma Specific mRNAs Exhibit In Vitro and In Vivo Efficacy
Naumann, J. A., Widen, J. C., Jonart, L. A., Ebadi, M., Tang, J. H., Gordon, D. J., Harki, D. A., & Gordon, P. M. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00774 · Cited by 23
Y Chromosome Loss and Implications for Oncology
Dirican, C. D., & Nelson, P. S. (2024) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-24-0105 · Cited by 22
Follow-Up Genotoxic Study: Chromosome Damage Two and Six Years after Exposure to the Prestige Oil Spill
Hildur, K., Templado, C., Zock, J., Giraldo, J., Pozo-Rodrı́guez, F., Francés, A., Monyarch, G., Rodríguez-Trigo, G., Rodríguez-Rodríguez, E., Souto-Alonso, A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132413 · Cited by 22
Cytogenetic analysis of an exposed-referent study: perchloroethylene-exposed dry cleaners compared to unexposed laundry workers
Tucker, J. D., Sorensen, K. J., Ruder, A. M., McKernan, L. T., Forrester, C. L., & Butler, M. A. (2011) · Environmental Health · doi:10.1186/1476-069x-10-16 · Cited by 22
Quantitative detection of rare interphase chromosome breaks and translocations by high-throughput imaging
Burman, B., Misteli, T., & Pegoraro, G. (2015) · Genome biology · doi:10.1186/s13059-015-0718-x · Cited by 22
Drug conjugated nanoparticles activated by cancer cell specific mRNA
Gossai, N. P., Naumann, J. A., Li, N., Zamora, E. A., Gordon, D. J., Piccirilli, J. A., & Gordon, P. M. (2016) · Oncotarget · doi:10.18632/oncotarget.9430 · Cited by 21
Chromosomal Bands Affected by Acute Oil Exposure and DNA Repair Errors
Monyarch, G., Reis, F. D. C., Zock, J., Giraldo, J., Pozo-Rodrı́guez, F., Espinosa, A., Rodríguez-Trigo, G., Verea, H., Castaño‐Vinyals, G., Gómez, F. P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081276 · Cited by 20
Chronic myeloid leukemia: cytogenetics and molecular biology’s part in the comprehension and management of the pathology and treatment evolution
Benchikh, S., Bousfiha, A., Hamouchi, A. E., Soro, S. G. C., Malki, A., & Nassereddine, S. (2022) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-022-00248-2 · Cited by 20
Chromosome translocations and assessing human exposure to adverse environmental agents
Tucker, J. D. (2010) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20561 · Cited by 20
Chromosomal instability and cancer: not just one CINgle mechanism
Boland, C. R., Komarova, N. L., & Goel, A. (2009) · Gut · doi:10.1136/gut.2008.160143 · Cited by 20
The search for cis-regulatory driver mutations in cancer genomes
Poulos, R. C., Sloane, M. A., Hesson, L. B., & Wong, J. W. H. (2015) · Oncotarget · doi:10.18632/oncotarget.5085 · Cited by 21
Persistence of Breakage in Specific Chromosome Bands 6 Years after Acute Exposure to Oil
Francés, A., Hildur, K., Barberà, J. A., Rodríguez-Trigo, G., Zock, J., Giraldo, J., Monyarch, G., Rodríguez-Rodríguez, E., Reis, F. D. C., Souto-Alonso, A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159404 · Cited by 20
Prostate cancer: The revolution of the fusion genes
Fernández‐Serra, A., Rubio‐Briones, J., García‐Casado, Z., Solsona, E., & López‐Guerrero, J. A. (2011) · Actas Urológicas Españolas (English Edition) · doi:10.1016/j.acuroe.2010.11.001 · Cited by 19
The crosstalk between non-coding RNAs and cell-cycle events: A new frontier in cancer therapy
Pathania, A. S., Chava, H., Balusu, R., Pasupulati, A. K., Coulter, D. W., & Challagundla, K. B. (2024) · Molecular Therapy Oncology · doi:10.1016/j.omton.2024.200785 · Cited by 19
Genes with Relevance for Early to Late Progression of Colon Carcinoma Based on Combined Genomic and Transcriptomic Information from the Same Patients
Lagerstedt, K. K., Kristiansson, E., Lönnroth, C., Andersson, M., Iresjö, B., Gustafsson, A., Hansson, E., Kressner, U., Nordgren, S., Enlund, F., et al. (2010) · Cancer Informatics · doi:10.4137/cin.s4545 · Cited by 19
Cáncer de próstata: la revolución de los genes de fusión
Fernández‐Serra, A., Rubio‐Briones, J., García‐Casado, Z., Solsona, E., & López‐Guerrero, J. A. (2011) · Actas Urológicas Españolas · doi:10.1016/j.acuro.2010.11.019 · Cited by 19
NCLcomparator: systematically post-screening non-co-linear transcripts (circular, trans-spliced, or fusion RNAs) identified from various detectors
Chen, C.-Y., & Chuang, T. (2019) · BMC Bioinformatics · doi:10.1186/s12859-018-2589-0 · Cited by 19

Authors: Fröhling, S., & Döhner, H.
Affiliations: Brigham and Women's Hospital (US)
University Hospital Ulm (DE)
ORCID: Fröhling, Stefan
Döhner, Hartmut
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2008-08-14
Volume: 359
Issue: 7
Pages: 722-734
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra0803109
OpenAlex: W1975410130
Cited by: 229
References: 94
Citations by year: 2025: 8 · 2024: 9 · 2023: 6 · 2022: 10 · 2021: 8 · 2020: 8 · 2019: 9 · 2018: 10 · 2017: 8 · 2016: 11 · 2015: 14 · 2014: 14 · 2013: 19 · 2012: 18
FWCI: 2.39
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords: chromosomal abnormalities, cancer, hematologic malignancies, solid tumors, prostate cancer, non-small cell lung cancer, cancer therapy targets, tumor diagnosis, prognosis
MeSH terms: Chromosome Aberrations, Chromosomes, Human, Humans, Neoplasms, Protein-Tyrosine Kinases, Transcription Factors, Translocation, Genetic, Gene Expression Regulation, Neoplastic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Chromosomal Abnormalities in Cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks